Paper30733
Direct and reflex myocardial effects of intracoronary administered contrast materials in the anesthetized and conscious dog: comparison of standard and newer contrast materials.
Higgins CB and 1 other. Invest Radiol, 1978. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Direct and reflex myocardial effects of intracoronary administered contrast materials in the anesthetized and conscious dog: comparison of standard and newer contrast materials. Papers, record 30733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Direct and reflex myocardial effects of intracoronary administered contrast materials in the anesthetized and conscious dog: comparison of standard and newer contrast materials.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contrast Media | Major topic |
| Heart | Major topic |
| Adrenergic beta-Antagonists | |
| Angiography | |
| Animals | |
| Coronary Angiography | |
| Diatrizoate Meglumine | |
| Dogs | |
| Hemodynamics | |
| Injections, Intra-Arterial | |
| Metrizamide | |
| Metrizoic Acid | |
| Myocardial Contraction | |
| Stimulation, Chemical |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7285049 | The influence of contrast media additives upon ventricular fibrillation thresholds during coronary angiography in ischemic and normal canine hearts. | Cardiovasc Intervent Radiol | 1981 | https://conductscience.org/library/papers/7285049 | PubMed |
| 7249015 | Effects of intracoronary administration of contrast materials on left ventricular function in the presence of severe coronary artery stenosis. | Cardiovasc Intervent Radiol | 1981 | https://conductscience.org/library/papers/7249015 | PubMed |
| 7206593 | [Reduced cardiotoxicity of contrast media in angiocardiography. Comparative clinical study using diatrizoate with added calcium or metrizamide (author's transl)]. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7206593 | PubMed |
| 6383445 | Contrast agents in angiocardiography. | Br Heart J | 1984 | https://conductscience.org/library/papers/6383445 | PubMed |
| 6217892 | A survey of contrast media used in coronary angiography. | Cardiovasc Intervent Radiol | 1982 | https://conductscience.org/library/papers/6217892 | PubMed |
| 2029351 | The adverse effects of angiographic radiocontrast media. | Drug Saf | 1991 | https://conductscience.org/library/papers/2029351 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30733
GET https://conductscience.org/api/papers/v1/30733/authors